US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sable Offshore Corp.

22.78

-0.1800-0.78%

Pre-market: 22.780.00000.00%04:51 EDT

Volume:1.50M

Turnover:34.39M

Market Cap:2.26B

PE:-3.05

High:23.70

Open:23.26

Low:22.58

Close:22.96

Loading ...

Overview Company News Filings

Sable Offshore Is Maintained at Sell by BWS Financial

Press Release: Sionna Therapeutics Reports First Quarter 2025 Financial Results

Press Release: Sable Offshore Corp. Reports First Quarter 2025 Financial and Operational Results

Sable Offshore Q1 EPS $(1.30) Misses $(0.76) Estimate

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference

Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)

Vodafone Business and Fortinet Expand Global Partnership to Secure Hybrid Work

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

Teradyne Reports First Quarter 2025 Results

CrowdStrike Holdings (NasdaqGS:CRWD) Launches AI-Driven Cybersecurity Innovations Revolutionizing SOC Operations

Simply Wall St.

IBM Delivers Autonomous Security Operations with Cutting-Edge Agentic AI

Rockwell Automation Unveils Powerful New Service to Detect and Respond to OT Cyber Threats

CrowdStrike Unleashes New Agentic, Outcome-Driven AI Innovations to Power the Next Evolution of the SOC

KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

N-able Report Reveals the Future of the SOC Relies on AI, While Human Intervention Remains Essential

Sable Offshore Files $1.5 Billion Mixed Shelf

MT Newswires Live

BRIEF-Sable Offshore Corp Files For Mixed Shelf Of Up To $1.5 Bln

Sable Offshore Corp Files for Mixed Shelf of up to $1.5 Bln- SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SOC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","market":"US","secType":"STK","nameCN":"Sable Offshore Corp.","latestPrice":22.78,"timestamp":1749844800000,"preClose":22.96,"halted":0,"volume":1504508,"hourTrading":{"tag":"盘前","latestPrice":22.78,"preClose":22.78,"latestTime":"04:51 EDT","volume":28,"amount":637.84,"timestamp":1750063904927},"delay":0,"floatShares":74348732,"shares":99338358,"eps":-7.480719,"marketStatus":"Pre-Mkt","change":-0.18,"latestTime":"06-16 05:21:30 EDT","open":23.26,"high":23.7012,"low":22.5801,"amount":34389867.836564004,"amplitude":0.048828,"askPrice":27.13,"askSize":100,"bidPrice":22.45,"bidSize":29,"shortable":3,"etf":0,"ttmEps":-7.480719,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1750080600000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":22.78,"preHourTrading":{"tag":"盘前","latestPrice":22.78,"preClose":22.78,"latestTime":"04:51 EDT","volume":28,"amount":637.84,"timestamp":1750063904927},"postHourTrading":{"tag":"盘后","latestPrice":23.13,"preClose":22.78,"latestTime":"19:58 EDT","volume":18102,"amount":412577.6381,"timestamp":1749859080191},"volumeRatio":0.7648189039097819,"impliedVol":0.8795,"impliedVolPercentile":0.4717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","floatShares":74348732,"roa":"-6.54%","roe":"-200.53%","lyrEps":-9.210924,"volumeRatio":0.7648189039097819,"shares":99338358,"dividePrice":0,"high":23.7012,"amplitude":0.048828,"preClose":22.96,"low":22.5801,"week52Low":13.66,"pbRate":"8.06","week52High":35,"institutionHeld":0,"latestPrice":22.78,"committee":-0.550388,"eps":-7.480719,"divideRate":0,"volume":1504508,"delay":0,"ttmEps":-7.480719,"open":23.26,"prevYearClose":22.9,"prevWeekClose":22.78,"prevMonthClose":28.78,"prevQuarterClose":25.37,"fiveDayClose":24.5,"twentyDayClose":28.06,"sixtyDayClose":25.95},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SOC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535779863","title":"Sable Offshore Is Maintained at Sell by BWS Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2535779863","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535779863?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:20","pubTimestamp":1747142400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SOC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 13, 2025 09:20 ET (13:20 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC"],"gpt_icon":0},{"id":"2534223775","title":"Press Release: Sionna Therapeutics Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534223775","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534223775?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:00","pubTimestamp":1747047600,"startTime":"0","endTime":"0","summary":"Phase 1 dosing completed for NBD1 stabilizers SION-719 & SION-451; both compounds continue to be generally well tolerated. On track to initiate Phase 2a proof-of-concept trial and at least one dual combination MAD trial in the second half of 2025; topline data for both anticipated in mid-2026. Strong cash position following completed upsized IPO, with approximately $354.7 million in cash and cash equivalents, expected to fund operations into 2028. \"Following our upsized IPO in February, we are in a strong financial position to advance our mission to transform the treatment paradigm for patients with CF,\" said Mike Cloonan, President and Chief Executive Officer of Sionna. \"We continue to execute across our pipeline and have completed dosing in our Phase 1 trials for both SION-719 and SION-451. We look forward to announcing topline data from these trials this quarter, and to initiating our Phase 2a POC trial and the combination MAD Phase 1 program later this year. With multiple meaningfu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION","CF","BK4093","BK4213","BK4588","BK4139","IPO","BK4585","SOC"],"gpt_icon":0},{"id":"2534196469","title":"Press Release: Sable Offshore Corp. Reports First Quarter 2025 Financial and Operational Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534196469","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534196469?lang=en_us&edition=fundamental","pubTime":"2025-05-10 06:04","pubTimestamp":1746828240,"startTime":"0","endTime":"0","summary":"Sable Offshore Corp.  today announced its first quarter 2025 financial and operational results.-- Reported a net loss of $109.5 million, primarily attributable to. production restart related operating expenses, non-cash interest expense,and a non-cash change in fair value of warrant liabilities.-- Ended the quarter with 89,338,358 shares of Common Stock outstanding.-- Concluded the quarter with outstanding debt of $854.6 million, inclusive. of paid-in-kind interest, additional principal incurred from the debt. -- Ended the quarter with cash and cash equivalents balance of $189.0. million, exclusive of restricted cash balance of $35.5 million.Sable Offshore Corp. is an independent oil and gas company, headquartered in Houston, Texas, focused on responsibly developing the Santa Ynez Unit in federal waters offshore California. The Sable team has extensive experience safely operating in California.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SOC"],"gpt_icon":0},{"id":"2534468860","title":"Sable Offshore Q1 EPS $(1.30) Misses $(0.76) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2534468860","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534468860?lang=en_us&edition=fundamental","pubTime":"2025-05-10 04:10","pubTimestamp":1746821430,"startTime":"0","endTime":"0","summary":"Sable Offshore (NYSE:SOC) reported quarterly losses of $(1.30) per share which missed the analyst consensus estimate of $(0.76) by 71.05 percent. This is a 56.52 percent increase over losses of $(2.99) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45329076/sable-offshore-q1-eps-1-30-misses-0-76-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC"],"gpt_icon":0},{"id":"2532822701","title":"International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2532822701","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532822701?lang=en_us&edition=fundamental","pubTime":"2025-05-02 21:30","pubTimestamp":1746192600,"startTime":"0","endTime":"0","summary":"SAN DIEGO, May 02, 2025  -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc.  that offers CLIA-certified laboratory developed tests  based on optical genome mapping , today announcedthe publication in the American Journal of Hematology of expert recommendations from the International Consortium for Optical Genome Mapping  for the integration of OGM as a standard-of-care  cytogenetic assay for diagnostic workflows in various clinical settings.Nineteen  experts from the ICOGM, representing relevant multidisciplinary fields, conducted an in-depth review of the classification of hematolymphoid malignancies using the World Health Organization  and ICC  criteria and published studies of OGM performance to assess whether OGM could provide a comprehensive analysis of the genome sufficient for better diagnosis, prognosis and treatment compared to existing SOC workflows across several indications. Based on the assessment, the ICOGM developed a set of expert recommendatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/international-consortium-optical-genome-mapping-133000963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMP","LU2413666426.HKD","BK4211","BK4588","LU2089279066.USD","LU2229751404.USD","BK4199","LU0347712357.USD","LU2413666699.HKD","BK4567","BK4575","BNGO","IE00BN0W2V16.EUR","BK4589","LU2092937221.SGD","SOC","BK4121","LU1721428933.USD","BK4088","LU1165135440.EUR","BK4124","A","BK4585","LU1543694498.USD","IE00BN0W2W23.USD","CCS","BK4207","OCC","ITP","BK4213","IE00BN0W2T93.GBP","CMA","LU2041044095.USD","BK4020"],"gpt_icon":0},{"id":"2532500381","title":"PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2532500381","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532500381?lang=en_us&edition=fundamental","pubTime":"2025-05-01 19:00","pubTimestamp":1746097200,"startTime":"0","endTime":"0","summary":"Late-breaking oral presentation to highlight further evidence supporting potential for deupirfenidone to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis . Regulatory and strategic planning underway to advance deupirfenidone into Phase 3 development. The presentation will highlight data from the recently completed Phase 2b ELEVATE IPF trial of deupirfenidone , which demonstrated unprecedented efficacy outcomes in patients living with idiopathic pulmonary fibrosis , including the potential to stabilize lung function decline at 26 weeks while maintaining safety and tolerability.The Phase 2b ELEVATE IPF trial was a global, randomized, double-blind, active- and placebo-controlled, dose-ranging trial designed to evaluate the efficacy, tolerability, safety, and dosing regimen of deupirfenidone  in patients with IPF compared to pl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/puretech-present-results-phase-2b-110000010.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATS","BK4108","BK4213","BK4117","AFG","FVC","SOC","BK4107","BK4139","PRTC","BK4161","LYT"],"gpt_icon":0},{"id":"2531032811","title":"Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2531032811","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531032811?lang=en_us&edition=fundamental","pubTime":"2025-04-30 20:29","pubTimestamp":1746016140,"startTime":"0","endTime":"0","summary":"First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older. IMAAVY delivered rapid and substantial reduction in immunoglobulin G  levels, one of the root causes of gMG, in both the adult and pediatric pivotal studies. gMG patients taking IMAAVY demonstrated 20 months of lasting disease control and symptom relief in the pivotal Vivacity-MG3 study and ongoing open-label extension . gMG is a chronic, debilitating autoantibody disease for which significant unmet patient need exists for additional efficacious therapies with demonstrated safety profiles that offer sustained disease control.2,3Anti-AChR and anti-MuSK antibody positive individuals comprise ≥90% of the total antibody-positive gMG population.4IMAAVY is an immunoselective therapy designed to substantially reduce immunoglobulin G , including harmful IgG autoantibodies, without additional detectable effects on other adaptive and innate immune functions.5. Pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/johnson-johnson-receives-fda-approval-122900395.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnson-receives-fda-approval-122900395.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1221951046.USD","IE0002141913.USD","BK4588","LU1059921491.USD","BK4592","MG","IE00B7SZLL34.SGD","LU1674673428.USD","LU1732799900.SGD","LU1196500208.SGD","IE00BN8TJ469.HKD","IE00B19Z4B17.USD","LU0795875169.SGD","LU0345769631.USD","LU0466842654.USD","BK4123","SG9999002232.USD","IE00BLSP4239.USD","LU1066051498.USD","SG9999001440.SGD","IE0031619046.USD","IE00BLSP4452.SGD","JNJ","LU1032955483.USD","LU1066053197.SGD","LU1244550221.USD","SOC","LU0289739699.SGD","IE0009355771.USD","LU1261432733.SGD","LU2129689431.USD","LU2430703178.SGD","LU1066051225.USD","BK4504","LU1244550494.USD","LU1221951129.SGD","LU2430703251.USD","LU0203345920.USD","LU2089984988.USD","LU0234572021.USD","LU1023059063.AUD","IE00B7SZL793.SGD","LU1894683264.USD","IE00B4R5TH58.HKD","LU1674673691.USD","LU0912757837.SGD","BK4532","BK4581","LU2129689514.USD","IE00B66KJ199.SGD"],"gpt_icon":0},{"id":"2531929754","title":"Vodafone Business and Fortinet Expand Global Partnership to Secure Hybrid Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2531929754","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531929754?lang=en_us&edition=fundamental","pubTime":"2025-04-29 21:00","pubTimestamp":1745931600,"startTime":"0","endTime":"0","summary":"Vodafone Business expands its converged networking and cybersecurity services powered by the Fortinet Unified SASE solution to new global markets.Vodafone Business has been also designated “Fortinet Global Partner” due to its expertise in designing, deploying, and managing secure connected enterprise solutions globally.Today’s announcement, with Vodafone Business attaining the “Fortinet Global Partner” status, underscores both companies’ commitment to supporting regional and international organizations across their IT and operational technology  environments. The value proposition also helps enterprises in meeting cybersecurity compliance standards and requirements.Joe Sarno, Executive Vice President, International Sales, Fortinet added: “As organizations digitize and scale across borders, secure connectivity is no longer optional—it’s essential. Our expanded partnership with Vodafone enabl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vodafone-business-fortinet-expand-global-130000099.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1064131342.USD","LU0079474960.USD","LU2286300806.USD","BK4187","LU2023250504.SGD","BK4516","IE0008368304.USD","BK4585","LU1974910355.USD","LU0348723411.USD","BK4532","FTNT","BK4213","NOC","LU2023250843.SGD","BK4603","LU1988902786.USD","BK4564","LU2264538146.SGD","LU1917777945.USD","BK4560","LU2106854487.HKD","BK4097","SOC","BK4588"],"gpt_icon":0},{"id":"2531816437","title":"Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2531816437","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531816437?lang=en_us&edition=fundamental","pubTime":"2025-04-29 18:45","pubTimestamp":1745923500,"startTime":"0","endTime":"0","summary":"Delivers Robust Earnings Performance, Successfully Navigating a Dynamic Environment. NEW YORK, April 29, 2025----Pfizer Inc.  reported financial results for the first quarter of 2025 and reaffirmed its 2025 financial guidance.\"Our overall solid first-quarter performance demonstrates our continued focus on commercial execution amid U.S. Medicare Part D headwinds. Our focus on operational efficiency and financial discipline is driving strong results to our bottom line. We are currently trending towards the upper end of our 2025 Adjusted diluted EPS guidance range.\". First-Quarter 2025 Revenues of $13.7 Billion, Reported Diluted EPS of $0.52, and Adjusted Diluted EPS of $0.92. On Track to Deliver Operating Margin Expansion from Ongoing Cost Realignment Program with Approximately $4.5 Billion of Net Cost Savings by End of 2025, and Announces Additional Productivity Gains Expected Through 2027 Leveraging Digital Enablement and Process Simplification. First Phase of Manufacturing Optimizatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-reports-solid-first-quarter-104500122.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B19Z3581.USD","BK4548","LU0170899867.USD","LU1894683264.USD","LU0225771236.USD","LU0122379950.USD","BK4022","LU0321505868.SGD","LU0321505439.SGD","SG9999002232.USD","BK4230","LU1894683348.USD","CAR","BK4581","LU1057294990.SGD","BK4135","EC","LU0868494617.USD","LU1066051498.USD","IE000M9KFDE8.USD","BCG","BK4568","BK4585","SGXZ57979304.SGD","BK4213","SOC","BK4535","BK4599","CDC","BK4550","SG9999013999.USD","BK4533","LU1066053197.SGD","LU0054578231.USD","LU0058720904.USD","PFE","SG9999002224.SGD","LU0225284248.USD","OS","BK4534","LU0289739699.SGD","ITT","BNTX","LU0234572021.USD","PFS","IE0002270589.USD","BK4195","LU0053671581.USD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2531729698","title":"Teradyne Reports First Quarter 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2531729698","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531729698?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:10","pubTimestamp":1745874600,"startTime":"0","endTime":"0","summary":"Revenue towards the high end and earnings above Q1 guidance ranges. Revenue of $686 million in Q1’25, up 14% from Q1’24. Board of Directors approves $1B share repurchase program. NORTH READING, Mass., April 28, 2025----Teradyne, Inc. :. In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude restructuring and other, acquired intangible assets amortization, ERP related expenses, inventory step-up, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/teradyne-reports-first-quarter-2025-211000579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","IE00BN0W2T93.GBP","BK4588","LU0444971666.USD","BK4213","IE00BN0W2W23.USD","LU1642822529.SGD","SOC","LU0957808578.USD","TER","BK4543","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4147","IE00BN0W2V16.EUR","LU1815336760.USD"],"gpt_icon":0},{"id":"2531252562","title":"CrowdStrike Holdings (NasdaqGS:CRWD) Launches AI-Driven Cybersecurity Innovations Revolutionizing SOC Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2531252562","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531252562?lang=en_us&edition=fundamental","pubTime":"2025-04-29 02:05","pubTimestamp":1745863554,"startTime":"0","endTime":"0","summary":"CrowdStrike Holdings recently introduced groundbreaking AI-powered solutions, including Charlotte AI and Falcon Adversary OverWatch, which have significantly enhanced the company's cybersecurity operations. These advancements could have contributed to the company's stock price increase of nearly 19% last month. While broader markets showed volatility due to economic concerns and fluctuating tech stocks, including declines in giants like Nvidia and Tesla, CrowdStrike’s innovative announcements likely bolstered its position, counterbalancing broader market movements. This positive momentum underscores their strong foothold in the cybersecurity sector, with technological advancements enhancing their appeal to investors.The recent introduction of CrowdStrike's AI-powered solutions, including Charlotte AI and Falcon Adversary OverWatch, aligns well with the company's strategic initiatives like Falcon Flex and AI capabilities mentioned in the analysis. These innovations potentially boost cus","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crowdstrike-holdings-nasdaqgs-crwd-launches-180554186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","LU0724618433.USD","LU2106854487.HKD","LU2264538146.SGD","LU2360107325.USD","LU2125909247.SGD","BK4141","LU2272731600.USD","BK4551","LU1548497426.USD","LU1854104046.USD","LU1923622614.USD","LU2286300806.USD","CRWD","IE00BD6J9T35.USD","IE00B894F039.SGD","BK4097","LU1951200564.SGD","LU1992135399.USD","IE00B19Z9P08.USD","LU2125909593.SGD","LU1923622291.USD","LU1861215975.USD","LU1720051108.HKD","BK4598","LU1923623000.USD","LU1988902786.USD","LU2272731782.SGD","ON","BK4528","LU1064131342.USD","BK4605","LU2125909759.SGD","LU1917777945.USD","LU1951198990.SGD","LU2433249047.HKD","SOC","LU1861220033.SGD","BK4543","BK4512","LU0081259029.USD","BK4585","BK4532","IE00BZ9MQY76.HKD","BK4213","LU1720051017.SGD","LU1861219969.SGD","LU1992135472.HKD","BK4560","LU2357305700.SGD"],"gpt_icon":1},{"id":"2530888892","title":"IBM Delivers Autonomous Security Operations with Cutting-Edge Agentic AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2530888892","media":"CNW Group","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530888892?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:00","pubTimestamp":1745845200,"startTime":"0","endTime":"0","summary":"New advanced AI capabilities help transform cybersecurity operations, driving efficiency and precision in threat hunting, detection, investigation and response. ARMONK, N.Y., April 28, 2025 /CNW/ -- IBM  today introduced new agentic and automation capabilities to its managed detection and response service offerings to help enable autonomous security operations and predictive threat intelligence for clients.IBM is launching Autonomous Threat Operations Machine , an agentic AI system providing autonomous threat triage, investigation, and remediation with minimal human intervention. IBM is also introducing the new X-Force Predictive Threat Intelligence  agent for ATOM, which leverages industry vertical-specific AI foundation models to generate predictive threat insights on potential adversarial activity and minimize manual threat hunting efforts.To extract early indicators of behavior and compromise, PTI gathers data from more than 100 sources including X-Force Threat Intelligence, open-s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ibm-delivers-autonomous-security-operations-130000514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4612","BK4213","BK4575","LU1430594728.SGD","SOC","LU1585245621.USD","LU1883839398.USD","IBM","LU1880398554.USD","BK4588","LU1778281490.HKD","BK4534","LU0321505868.SGD","BK4543","BK4147","BK4602","LU1674673691.USD","LU1880398471.USD","BK4538","BK4585","LU1674673428.USD","LU0321505439.SGD","LU0868494617.USD","BK4134","BK4533","BK4579","ATOM"],"gpt_icon":1},{"id":"2530714754","title":"Rockwell Automation Unveils Powerful New Service to Detect and Respond to OT Cyber Threats","url":"https://stock-news.laohu8.com/highlight/detail?id=2530714754","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530714754?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:00","pubTimestamp":1745838000,"startTime":"0","endTime":"0","summary":"MILWAUKEE, April 28, 2025 /CNW/ --Rockwell Automation, Inc. , the world's largest company dedicated to industrial automation and digital transformation, today announced its Security Monitoring and Response service, which is purpose-built to deliver continuous, real-time monitoring of operational technology  environments. Security Monitoring and Response seamlessly integrates into existing architecture to help industrial organizations stay ahead of cyber threats and build resilient operations.Continuous monitoring and advanced threat detection:24/7 real-time monitoring of OT environments provides continuous surveillance and rapid detection of potential threats. Rockwell OT cybersecurity analysts use advanced analytics to prioritize and investigate alerts, transforming raw data into actionable insights.Through early detection and mitigation of threats, Security Monitoring and Response can help reduce disruption, downtime and potential financial losses, improving operational efficiency by","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rockwell-automation-unveils-powerful-detect-110000147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ROK","BK4213","LU0154245756.USD","LU0689626769.HKD","BK4588","LU1894683348.USD","BK4580","BK4585","LU0124676726.USD","LU0154245673.USD","SOC","BK4096","LU0390134368.USD","LU1894683264.USD"],"gpt_icon":0},{"id":"2530441839","title":"CrowdStrike Unleashes New Agentic, Outcome-Driven AI Innovations to Power the Next Evolution of the SOC","url":"https://stock-news.laohu8.com/highlight/detail?id=2530441839","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530441839?lang=en_us&edition=fundamental","pubTime":"2025-04-28 15:01","pubTimestamp":1745823660,"startTime":"0","endTime":"0","summary":"Charlotte AI unites intelligent automation with human cyber expertise, accelerating detection, investigation and response across the AI-native SOC. AUSTIN, Texas & SAN FRANCISCO, April 28, 2025----RSA 2025 - CrowdStrike  today unveiled Charlotte AI Agentic Response and Charlotte AI Agentic Workflows, marking a leap forward in modern SOC operations. Combined with the previously announced Charlotte AI Agentic Detection Triage, Charlotte AI transcends \"ask-and-respond\" copilots, delivering autonomous reasoning and action on first- and third-party data. The AI-native CrowdStrike Falcon platform is now cybersecurity’s intelligent reasoning AI platform, drawing conclusions without human prompts and taking action with bounded autonomy.Falcon Complete with Charlotte AI: Falcon Complete Next-Gen MDR analysts now levera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/crowdstrike-unleashes-agentic-outcome-driven-070100492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BZ199S13.USD","LU2125909593.SGD","BK4097","LU1974910355.USD","LU1917777945.USD","LU2211815571.USD","BK4605","LU1548497426.USD","BK4234","BK4528","LU1951200564.SGD","LU2125909247.SGD","CRWD","LU1720051017.SGD","LU2360107325.USD","LU2433249047.HKD","ON","LU1923623000.USD","LU0081259029.USD","LU1861214812.USD","LU2264538146.SGD","BK4543","SOC","LU1992135399.USD","BK4532","LU1854104046.USD","LU1992135472.HKD","BK4084","LU1861220033.SGD","EPM","LU2286300806.USD","BK4588","BK4585","LU1951198990.SGD","LU1861219969.SGD","LU2023250504.SGD","LU2106854487.HKD","BK4560","PW","LU0724618433.USD","LU1988902786.USD","IE00BD6J9T35.USD","BK4213","LU1923622614.USD","LU2125909916.SGD","BK4512","IE00B894F039.SGD","LU1720051108.HKD","LU0124384867.USD","BK4598"],"gpt_icon":1},{"id":"2530548354","title":"KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530548354","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530548354?lang=en_us&edition=fundamental","pubTime":"2025-04-28 00:00","pubTimestamp":1745769600,"startTime":"0","endTime":"0","summary":"KEYNOTE-689 marks the first positive trial in more than two decades for patients with resected locally advanced head and neck squamous cell carcinoma . Results to be presented at American Association for Cancer Research  Annual Meeting 2025 during a Plenary Session and included in official meeting press program. \"As the first positive trial in over two decades for patients with resectable, locally advanced head and neck squamous cell carcinoma, the presentation of these landmark results marks an important moment for these patients and those who care for them,\" said Dr. Ravindra Uppaluri, the study’s co-principal investigator, director of Head and Neck Surgical Oncology, Brigham and Women’s Hospital and Dana-Farber","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keytruda-pembrolizumab-perioperative-treatment-standard-160000135.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1162221912.USD","BTC","LU1037948541.HKD","LU2298322129.HKD","IE0009355771.USD","SG9999014567.USD","SGXZ57979304.SGD","LU1854103824.USD","SG9999015358.SGD","LU0054578231.USD","LU0289739699.SGD","LU0861579265.USD","LU1934455194.USD","AEIS","ON","BK4605","LU1066051225.USD","CRT","LU0320765489.SGD","ITT","IE00B7SZL793.SGD","LU0265550946.USD","CRC","BK4097","LU2361044865.SGD","HCC","LU0320765646.SGD","SMP","ALT","LU2106854487.HKD","LU2361044949.HKD","HSCT","IE00BLSP4239.USD","LU0208291251.USD","OS","BK4161","LU1430594728.SGD","CPS","BK4533","IE00BZ199S13.USD","LU2023250843.SGD","BCG","MRK","LU1861220033.SGD","SG9999001440.SGD","IE00BLSP4452.SGD","SOC","RCC","DM","BK4135"],"gpt_icon":0},{"id":"2530175929","title":"Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2530175929","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530175929?lang=en_us&edition=fundamental","pubTime":"2025-04-27 01:30","pubTimestamp":1745688600,"startTime":"0","endTime":"0","summary":"Pivotal Phase 3 CREST trial results show a 32% reduction in the risk of disease-related events, including high-grade disease recurrence or progression, with sasanlimab in combination with standard of care  Bacillus Calmette-Guérin  regimen compared to SOC alone. Sasanlimab, a subcutaneously administered PD-1 inhibitor, in combination with BCG represents the first potential treatment advancement for BCG-nave, high-risk non-muscle invasive bladder cancer in more than 30 years. Results have been shared with global health authorities to support potential regulatory filings. \"New bladder cancer treatment options that help reduce rates of disease recurrence or progression are long overdue. Up to 50% of patients with high-risk non-muscle invasive bladder cancer may experience failure of BCG intravesical immunotherapy, yet it has been the standard of care after tumor resection for decades,\" said Neal Shore, M.D., FACS, Medical Director for START Carolina Research Center, and lead investigator ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-sasanlimab-combination-significantly-improves-173000786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0306806265.USD","SG9999002232.USD","LU1057294990.SGD","BK4007","CR","SG9999011175.SGD","IE0002270589.USD","IE00BBT3K403.USD","BK4588","BK4534","BK4533","BK4203","LU0170899867.USD","LU0122379950.USD","PFE","BK4581","BCG","BK4135","LU0234572021.USD","SG9999003800.SGD","ADC","CI","IE000M9KFDE8.USD","LU0225771236.USD","LU1059921491.USD","BK4550","LU0289739699.SGD","LU0985481810.HKD","SGXZ57979304.SGD","LU1066053197.SGD","BK4231","SG9999002224.SGD","LU0456855351.SGD","OS","BK4585","SOC","LU1883839398.USD","HR","SG9999001176.USD","BK4592","LU1894683348.USD","LU1023059063.AUD","BK4213","SG9999013999.USD","IE00BLSP4239.USD","BK4097","LU0321505439.SGD","LU1261432733.SGD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"2529062176","title":"N-able Report Reveals the Future of the SOC Relies on AI, While Human Intervention Remains Essential","url":"https://stock-news.laohu8.com/highlight/detail?id=2529062176","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529062176?lang=en_us&edition=fundamental","pubTime":"2025-04-24 18:00","pubTimestamp":1745488800,"startTime":"0","endTime":"0","summary":"As cybersecurity challenges intensify, AI will fuel Security Operations Center  advancements and empower human analysts to improve defense and overcome alert fatigue. Cyberthreats have intensified, testing the resilience of security teams as attackers grow more elusive and relentless. SOCs remain a critical line of defense—but keeping pace demands more than traditional playbooks. Integrating AI into SOC workflows isn’t just a strategic shift—we believe it’s a major key to unlocking new levels of efficiency that the human factor alone can’t deliver. From accelerating detections to automating investigations and reporting, AI empowers analysts to focus on what truly matters: anticipating threats, not just reacting to them.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/n-able-report-reveals-future-100000888.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861220033.SGD","IE00BZ199S13.USD","LU0348723411.USD","BK4141","LU1854104046.USD","LU0124384867.USD","BK4213","LU1854103824.USD","LU1548497426.USD","BK4605","LU2357305700.SGD","LU1861215975.USD","BK4097","LU1861219969.SGD","LU2298322129.HKD","BK4512","LU1720051108.HKD","SOC","BK4588","LU1861214812.USD","LU1720051017.SGD","LU1978683503.SGD","NABL","LU0724618433.USD","BK4585","IE00BD6J9T35.USD","ON","LU2360107325.USD"],"gpt_icon":0},{"id":"2529659605","title":"Sable Offshore Files $1.5 Billion Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2529659605","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529659605?lang=en_us&edition=fundamental","pubTime":"2025-04-23 05:32","pubTimestamp":1745357553,"startTime":"0","endTime":"0","summary":"Sable Offshore (SOC) filed a registration statement Tuesday with the US Securities and Exchange Commission for the potential sale of up to $1.5 billion in securities from time to time in one or more offerings.The filing covers common and preferred stock, debt securities, warrants and units.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4213","BK7061","SOC","SOC.AU"],"gpt_icon":0},{"id":"2529550041","title":"BRIEF-Sable Offshore Corp  Files For Mixed Shelf Of Up To $1.5 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2529550041","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529550041?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:57","pubTimestamp":1745355435,"startTime":"0","endTime":"0","summary":"BRIEF-Sable Offshore Corp  Files For Mixed Shelf Of Up To $1.5 BlnApril 22 (Reuters) - Sable Offshore Corp SOC.N:SABLE OFFSHORE CORP  FILES FOR MIXED SHELF OF UP TO $1.5 BILLION- SEC FILINGSource text: [ID:n0001628280-25-018856]Further company coverage: SOC.N ((Reuters.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R0248:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SOC","BK4213"],"gpt_icon":0},{"id":"2529552565","title":"Sable Offshore Corp  Files for Mixed Shelf of up to $1.5 Bln- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2529552565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529552565?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:21","pubTimestamp":1745353310,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R0248:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SOC","BK4213"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":4,"totalSize":177,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SOC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"SOC","fiscalQuarterEnding":"2025/03","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"post","actualEps":-1.05},{"market":"US","date":"2025-03-17","symbol":"SOC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"SOC","fiscalQuarterEnding":"2024/09","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-1.24},{"market":"US","date":"2024-08-13","symbol":"SOC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.75},{"date":"2024-05-15","symbol":"SOC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715803200000,"name":null,"time":"Post Market","dateTimestamp":1715745600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SOC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1743134400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SOC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SOC","date":"2025-06-13","current":-4.171827,"percent":0.58147,"low":-49.514744,"twenty":-14.252336,"median":-4.392209,"eighty":-3.509534,"high":-2.360887,"avg":-9.728279,"sd":12.82423,"marketCap":2280808699},"quantilePoints":[{"date":"2024-02-16","current":-10.965511,"twenty":-10.965511,"median":-10.965511,"eighty":-10.965511,"marketCap":164955978},{"date":"2024-02-23","current":-47.994905,"twenty":-48.050899,"median":-47.994905,"eighty":-40.589026,"marketCap":721995228},{"date":"2024-03-01","current":-48.874812,"twenty":-48.810818,"median":-47.994905,"eighty":-47.810925,"marketCap":735231807},{"date":"2024-03-08","current":-48.51485,"twenty":-48.842815,"median":-48.51485,"eighty":-47.970908,"marketCap":729816842},{"date":"2024-03-15","current":-46.995011,"twenty":-48.834816,"median":-48.13489,"eighty":-47.810925,"marketCap":706953660},{"date":"2024-03-22","current":-44.715253,"twenty":-48.802819,"median":-47.994905,"eighty":-46.491065,"marketCap":672658887},{"date":"2024-03-28","current":-44.475279,"twenty":-48.79482,"median":-47.954909,"eighty":-44.667258,"marketCap":669048911},{"date":"2024-04-05","current":-20.510023,"twenty":-48.626838,"median":-47.554952,"eighty":-43.603371,"marketCap":660023970},{"date":"2024-04-12","current":-20.47263,"twenty":-48.442858,"median":-46.715041,"eighty":-20.502545,"marketCap":658820645},{"date":"2024-04-19","current":-19.182574,"twenty":-48.32287,"median":-44.795244,"eighty":-20.47263,"marketCap":617305919},{"date":"2024-04-26","current":-19.5752,"twenty":-48.106893,"median":-44.595266,"eighty":-20.42028,"marketCap":629940836},{"date":"2024-05-03","current":-19.593896,"twenty":-47.994905,"median":-43.535379,"eighty":-19.762164,"marketCap":630542499},{"date":"2024-05-10","current":-20.659595,"twenty":-47.994905,"median":-20.566113,"eighty":-19.777121,"marketCap":664837272},{"date":"2024-05-17","current":-26.212445,"twenty":-47.994905,"median":-20.911997,"eighty":-19.833211,"marketCap":843531091},{"date":"2024-05-24","current":-4.001469,"twenty":-47.970907,"median":-20.566113,"eighty":-19.605114,"marketCap":803821353},{"date":"2024-05-31","current":-4.492667,"twenty":-47.922913,"median":-20.510023,"eighty":-19.496675,"marketCap":902494035},{"date":"2024-06-07","current":-4.456726,"twenty":-47.746932,"median":-20.481978,"eighty":-19.242403,"marketCap":895274082},{"date":"2024-06-14","current":-4.444746,"twenty":-47.554952,"median":-20.47263,"eighty":-4.563951,"marketCap":892867431},{"date":"2024-06-21","current":-4.336922,"twenty":-47.554952,"median":-20.47263,"eighty":-4.498658,"marketCap":871207575},{"date":"2024-06-28","current":-4.375858,"twenty":-47.330976,"median":-20.453933,"eighty":-4.49087,"marketCap":879029190},{"date":"2024-07-05","current":-4.729281,"twenty":-46.939017,"median":-20.360451,"eighty":-4.493865,"marketCap":950025387},{"date":"2024-07-12","current":-4.666384,"twenty":-46.491065,"median":-20.080004,"eighty":-4.499856,"marketCap":937390471},{"date":"2024-07-15","current":-4.792179,"twenty":-46.267089,"median":-20.014567,"eighty":-4.501054,"marketCap":962660304},{"date":"2024-08-02","current":-4.753242,"twenty":-46.043112,"median":-19.949129,"eighty":-4.502252,"marketCap":954838689},{"date":"2024-08-09","current":-4.193156,"twenty":-45.163206,"median":-19.771513,"eighty":-4.476494,"marketCap":842327766},{"date":"2024-08-16","current":-2.818059,"twenty":-44.779246,"median":-19.612593,"eighty":-4.43576,"marketCap":969439268},{"date":"2024-08-23","current":-2.836909,"twenty":-44.643261,"median":-19.584548,"eighty":-4.379452,"marketCap":975923811},{"date":"2024-08-30","current":-3.106462,"twenty":-44.595266,"median":-19.425628,"eighty":-4.335724,"marketCap":1068652785},{"date":"2024-09-06","current":-4.073462,"twenty":-44.547271,"median":-19.332146,"eighty":-4.230058,"marketCap":1401309871},{"date":"2024-09-13","current":-3.988638,"twenty":-44.235304,"median":-7.878845,"eighty":-4.193156,"marketCap":1372129425},{"date":"2024-09-20","current":-5.33452,"twenty":-43.603371,"median":-4.857618,"eighty":-4.199566,"marketCap":1835125838},{"date":"2024-09-27","current":-5.343032,"twenty":-36.402227,"median":-4.781696,"eighty":-4.199566,"marketCap":1838054195},{"date":"2024-10-04","current":-5.755604,"twenty":-24.956043,"median":-4.880237,"eighty":-4.209959,"marketCap":1979982860},{"date":"2024-10-11","current":-4.598218,"twenty":-22.592809,"median":-4.868927,"eighty":-4.213365,"marketCap":1581830780},{"date":"2024-10-18","current":-4.725113,"twenty":-21.590679,"median":-4.792179,"eighty":-4.229539,"marketCap":1625484098},{"date":"2024-10-25","current":-4.888949,"twenty":-20.962478,"median":-4.790222,"eighty":-4.249285,"marketCap":1681845104},{"date":"2024-10-31","current":-4.998173,"twenty":-20.648377,"median":-4.810961,"eighty":-4.266836,"marketCap":1719419108},{"date":"2024-11-08","current":-5.61315,"twenty":-20.596027,"median":-4.880237,"eighty":-4.334526,"marketCap":1930977089},{"date":"2024-11-15","current":-3.401519,"twenty":-20.554895,"median":-4.900821,"eighty":-4.334526,"marketCap":2003855918},{"date":"2024-11-22","current":-3.557753,"twenty":-20.510023,"median":-4.857618,"eighty":-4.212246,"marketCap":2051078846},{"date":"2024-11-29","current":-3.628847,"twenty":-20.510023,"median":-4.805844,"eighty":-4.193156,"marketCap":2092064783},{"date":"2024-12-06","current":-2.944188,"twenty":-20.491327,"median":-4.779739,"eighty":-4.113047,"marketCap":1697352390},{"date":"2024-12-13","current":-3.083283,"twenty":-20.491327,"median":-4.753242,"eighty":-3.988638,"marketCap":1777542266},{"date":"2024-12-20","current":-3.440295,"twenty":-20.47263,"median":-4.727197,"eighty":-3.815772,"marketCap":1983362950},{"date":"2024-12-27","current":-3.676757,"twenty":-20.47263,"median":-4.697136,"eighty":-3.712613,"marketCap":2119685740},{"date":"2025-01-03","current":-3.597937,"twenty":-20.47263,"median":-4.668442,"eighty":-3.657593,"marketCap":2074244810},{"date":"2025-01-10","current":-3.51757,"twenty":-20.47263,"median":-4.649598,"eighty":-3.630083,"marketCap":2027912881},{"date":"2025-01-17","current":-3.811216,"twenty":-20.47263,"median":-4.615467,"eighty":-3.610301,"marketCap":2197202621},{"date":"2025-01-24","current":-4.367598,"twenty":-20.465151,"median":-4.609477,"eighty":-3.628847,"marketCap":2517962128},{"date":"2025-01-31","current":-3.859127,"twenty":-20.427758,"median":-4.5959,"eighty":-3.629465,"marketCap":2224823579},{"date":"2025-02-07","current":-3.491297,"twenty":-20.382887,"median":-4.55257,"eighty":-3.628847,"marketCap":2012765905},{"date":"2025-02-14","current":-4.733883,"twenty":-20.293145,"median":-4.531604,"eighty":-3.604119,"marketCap":2729128803},{"date":"2025-02-21","current":-4.54224,"twenty":-20.173487,"median":-4.551073,"eighty":-3.628847,"marketCap":2618644973},{"date":"2025-02-28","current":-4.291868,"twenty":-20.080004,"median":-4.534513,"eighty":-3.628847,"marketCap":2474303195},{"date":"2025-03-07","current":-3.568572,"twenty":-19.949129,"median":-4.506443,"eighty":-3.628847,"marketCap":2057315836},{"date":"2025-03-14","current":-3.656666,"twenty":-19.855647,"median":-4.498658,"eighty":-3.616483,"marketCap":2108102758},{"date":"2025-03-21","current":-3.688441,"twenty":-19.799557,"median":-4.493498,"eighty":-3.616483,"marketCap":2320276640},{"date":"2025-03-28","current":-3.714026,"twenty":-19.743468,"median":-4.48816,"eighty":-3.616483,"marketCap":2336371044},{"date":"2025-04-04","current":-3.081519,"twenty":-19.706075,"median":-4.44175,"eighty":-3.606002,"marketCap":1938481601},{"date":"2025-04-11","current":-2.477439,"twenty":-19.612593,"median":-4.43576,"eighty":-3.570468,"marketCap":1558474829},{"date":"2025-04-17","current":-2.787296,"twenty":-19.597635,"median":-4.41653,"eighty":-3.557444,"marketCap":1753395950},{"date":"2025-04-25","current":-2.787296,"twenty":-19.593896,"median":-4.401482,"eighty":-3.529934,"marketCap":1753395950},{"date":"2025-05-02","current":-2.841765,"twenty":-19.578939,"median":-4.381848,"eighty":-3.496243,"marketCap":1787660543},{"date":"2025-05-09","current":-2.978101,"twenty":-19.4705,"median":-4.366826,"eighty":-3.412757,"marketCap":1873425367},{"date":"2025-05-16","current":-4.5891,"twenty":-19.429367,"median":-4.367598,"eighty":-3.435349,"marketCap":2508938825},{"date":"2025-05-23","current":-5.794479,"twenty":-19.410671,"median":-4.383223,"eighty":-3.441532,"marketCap":3167939997},{"date":"2025-05-30","current":-4.998561,"twenty":-19.36206,"median":-4.401482,"eighty":-3.471515,"marketCap":2732798228},{"date":"2025-06-06","current":-4.217252,"twenty":-19.242403,"median":-4.399819,"eighty":-3.495006,"marketCap":2305643289},{"date":"2025-06-13","current":-4.171827,"twenty":-14.252336,"median":-4.392209,"eighty":-3.509534,"marketCap":2280808699}],"updateTime":1750065690075}}}